* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 4000 tests per day.

Total Reported: 587,000+

Turnaround

0.5 Days

Please email our courier service department for fast and reliable specimen pickup and transfer.

NEWS & RESOURCES

FDA-EU

Ipsum Diagnostics, LLC, or other laboratories designated by Ipsum Diagnostics, LLC that are also certified under the ClinicalLaboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C.§263a,

Read More »